Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Communication Disorders 1

Interventions

Cyclophosphamide 222 pembrolizumab 201 Carboplatin 173 Cisplatin 168 Gemcitabine 167 Paclitaxel 155 Docetaxel 140 Bevacizumab 138 Rituximab 137 Radiotherapy 137 Nivolumab 126 Dexamethasone 126 Capecitabine 103 fludarabine 102 Pemetrexed 92 fludarabine phosphate 91 Fluorouracil 91 Doxorubicin 85 Oxaliplatin 79 Etoposide 77 Cytarabine 77 Bortezomib 76 Erlotinib Hydrochloride 74 Leucovorin 72 Filgrastim 68 Lenalidomide 67 Calcium Dobesilate 66 Irinotecan 65 atezolizumab 63 Radiation 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Has results × Speech Therapy × Clear all

NCT05189366 2026-04-14

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated

13 enrolled 8 charts

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡